3Filing Date: Sep 10, 2026
Dexcom (DXCM)
Initial Statement of Beneficial Ownership
View SEC Filing
ACC: 0001093557-26-000169
Total Value$0
Trades1
Insiders1
Transaction Details
Boehnlein Glenn S
Director·Indirect · By Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After42
Footnotes ▸
Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.
Post-Transaction Holdings
Boehnlein Glenn S · Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 42 | - |
Original SEC Filing Textexpand_more
=== SEC Form 3 — Statement of Changes in Beneficial Ownership ===
Document Type: 3
Period of Report: 2026-09-10
--- Issuer ---
Name: DEXCOM INC (DXCM)
CIK: 0001093557
--- Reporting Owner ---
Name: Boehnlein Glenn S
CIK: 0001670936
Role: Director
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
Footnotes:
[F1] Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.
--- Footnotes (Complete Index) ---
F1: Shares are held by the Boehnlein 2017 Trust, with respect to which the Reporting Person and the Reporting Person's spouse are co-trustees.
--- Signature ---
/s/ /s/ Jereme M. Sylvain, as Attorney-in-Fact for Glenn S. Boehnlein (2026-09-10)